MiR-302b suppresses HCC hyperplasia due to associating with proliferation-related proteins, such as AKT2, CCND1, and CDK2, targeting the EGFR/AKT2/CCND1 pathway [16]. This evidence concerns the gene CCND1 and hepatocellular carcinoma.